Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
May-2017 Volume 15 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
May-2017 Volume 15 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Immunomodulatory effects in workers exposed to naturally occurring asbestos fibers

  • Authors:
    • Caterina Ledda
    • Chiara Costa
    • Serena Matera
    • Beatrice Puglisi
    • Valentina Costanzo
    • Massimo Bracci
    • Concettina Fenga
    • Venerando Rapisarda
    • Carla Loreto
  • View Affiliations / Copyright

    Affiliations: Section of Occupational Medicine, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy, Section of Occupational Medicine, Department of Biomedical, Odontoiatric, Morphological and Functional Images, University of Messina, Messina, Italy, Section of Occupational Medicine, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy, Section of Human Anatomy and Histology, Department of Biomedical and Biotechnology Sciences, University of Catania, Catania, Italy
  • Pages: 3372-3378
    |
    Published online on: March 24, 2017
       https://doi.org/10.3892/mmr.2017.6384
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Natural asbestiform fibers are defined ‘naturally occurring asbestos’ (NOA) and refer to the mineral as a natural component of soils or rocks. The release of NOA fibers into the air from rocks or soils by routine human activities or natural weathering processes represents a risk for human beings. Fluoro-edenite (FE) is a NOA fiber detected in the benmoreitic lava in the area of Biancavilla, South-west slope of Mt. Etna. The aim of the present study was to investigate FE immunotoxicity pathways in a group of 38 occupationally exposed construction workers, in order to find any biological markers of its effect. Subjects underwent respiratory function tests and HRCT total chest scanning. Serum IL-1β, IL-6, IL-8 and TNF-α were measured. The presence of PPs was significantly greater in subjects exposed than in the control (25 vs. 2). In subjects exposed to FE, IL-1β and TNF-α values were significantly higher than the controls. The previously observed increase of IL-1β and IL-18 showed a probable involvement of the proteic complex defined inflammosome by FE fibers.
View Figures

Figure 1

View References

1 

Alberg AJ and Samet JM: Epidemiology of lung cancer. Chest. 123:(Suppl). 21S–49S. 2003. View Article : Google Scholar : PubMed/NCBI

2 

LaDou J: The asbestos cancer epidemic. Environ Health Perspect. 112:285–290. 2004. View Article : Google Scholar : PubMed/NCBI

3 

Fujimoto N, Gemba K, Aoe K, Kato K, Yokoyama T, Usami I, Onishi K, Mizuhashi K, Yusa T and Kishimoto T: Clinical investigation of benign asbestos pleural effusion. Pulm Med. 2015:4161792015. View Article : Google Scholar : PubMed/NCBI

4 

Prazakova S, Thomas PS, Sandrini A and Yates DH: Asbestos and the lung in the 21st century: An update. Clin Respir J. 8:1–10. 2014. View Article : Google Scholar : PubMed/NCBI

5 

Hillerdal G: Non-malignant asbestos pleural disease. Thorax. 36:669–675. 1981. View Article : Google Scholar : PubMed/NCBI

6 

Guidotti TL, Miller A, Christiani D, Wagner G, Balmes J, Harber P, Brodkin CA, Rom W, Hillerdal G, Harbut M, et al: American Thoracic Society: Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med. 170:691–715. 2004. View Article : Google Scholar : PubMed/NCBI

7 

Cugell DW and Kamp DW: Asbestos and the pleura: A review. Chest. 125:1103–1117. 2004. View Article : Google Scholar : PubMed/NCBI

8 

Gevenois PA, de Maertelaer V, Madani A, Winant C, Sergent G and De Vuyst P: Asbestosis, pleural plaques and diffuse pleural thickening: Three distinct benign responses to asbestos exposure. Eur Respir J. 11:1021–1027. 1998. View Article : Google Scholar : PubMed/NCBI

9 

Bayram M, Dongel I, Bakan ND, Yalçin H, Cevit R, Dumortier P and Nemery B: High risk of malignant mesothelioma and pleural plaques in subjects born close to ophiolites. Chest. 143:164–171. 2013. View Article : Google Scholar : PubMed/NCBI

10 

Kanarek MS: Mesothelioma from chrysotile asbestos: Update. Ann Epidemiol. 21:688–697. 2011. View Article : Google Scholar : PubMed/NCBI

11 

Hansen J, de Klerk NH, Eccles JL, Musk AW and Hobbs MS: Malignant mesothelioma after environmental exposure to blue asbestos. Int J Cancer. 54:578–581. 1993. View Article : Google Scholar : PubMed/NCBI

12 

Constantopoulos SH: Environmental mesothelioma associated with tremolite asbestos: Lessons from the experiences of Turkey, Greece, Corsica, New Caledonia and Cyprus. Regul Toxicol Pharmacol. 52:(Suppl 1). S110–S115. 2008. View Article : Google Scholar : PubMed/NCBI

13 

Voisin C, Marin I, Brochard P and Pairon JC: Environmental airborne tremolite asbestos pollution and pleural plaques in Afghanistan. Chest. 106:974–976. 1994. View Article : Google Scholar : PubMed/NCBI

14 

Schüz J, Schonfeld SJ, Kromhout H, Straif K, Kashanskiy SV, Kovalevskiy EV, Bukhtiyarov IV and McCormack V: A retrospective cohort study of cancer mortality in employees of a Russian chrysotile asbestos mine and mills: Study rationale and key features. Cancer Epidemiol. 37:440–445. 2013. View Article : Google Scholar : PubMed/NCBI

15 

Sullivan PA: Vermiculite, respiratory disease, and asbestos exposure in Libby, Montana: Update of a cohort mortality study. Environ Health Perspect. 115:579–585. 2007. View Article : Google Scholar : PubMed/NCBI

16 

Szychlinska MA, Parenti R, Loreto C, Salvatorelli L, Spadola S, Trovato FM, Pirri C, Rapisarda V, Pace MM, Magro G, et al: Fluoro edenite-associated pathogenesis in pleural malignant mesothelioma. Acta Med Mediter. 30:981–989. 2014.

17 

Paoletti L, Batisti D, Bruno C, Di Paola M, Gianfagna A, Mastrantonio M, Nesti M and Comba P: Unusually high incidence of malignant pleural mesothelioma in a town of eastern Sicily: An epidemiological and environmental study. Arch Environ Health. 55:392–398. 2000. View Article : Google Scholar : PubMed/NCBI

18 

Di Paola M, Mastrantonio M and Carboni M: Mortality from malignant pleural neoplasms in Italy in the years 1988–1992ISTISAN. 96. Rome: pp. 1–30. 1996

19 

Comba P, Gianfagna A and Paoletti L: Pleural mesothelioma cases in Biancavilla are related to a new fluoro-edenite fibrous amphibole. Arch Environ Health. 58:229–232. 2003. View Article : Google Scholar : PubMed/NCBI

20 

Miozzi E, Rapisarda V, Marconi A, Costa C, Polito I, Spandidos DA, Libra M and Fenga C: Fluoro-edenite and carbon nanotubes: The health impact of ‘asbestos-like’ fibres. Exp Ther Med. 11:21–27. 2016.PubMed/NCBI

21 

Ballan G, Del Brocco A, Loizzo S, Fabbri A, Maroccia Z, Fiorentini C and Travaglione S: Mode of action of fibrous amphiboles: The case of Biancavilla (Sicily, Italy). Ann Ist Super Sanita. 50:133–138. 2014.PubMed/NCBI

22 

DeNardo P, Bruni B, Paoletti L, Pasetto R and Sirianni B: Pulmonary fibre burden in sheep living in the Biancavilla area (Sicily): Preliminary results. Sci Total Environ. 325:51–58. 2004. View Article : Google Scholar : PubMed/NCBI

23 

Loreto C, Rapisarda V, Carnazza ML, Musumeci G, Valentino M, Fenga C and Martinez G: Fluoro-edenite fibres induce lung cell apoptosis: An in vivo study. Histol Histopathol. 23:319–326. 2008.PubMed/NCBI

24 

Martinez G, Loreto C, Rapisarda V, Masumeci G, Valentino M and Carnazza ML: Effects of exposure to fluoro-edenite fibre pollution on the respiratory system: An in vivo model. Histol Histopathol. 21:595–601. 2006.PubMed/NCBI

25 

Soffritti M, Minardi F, Bua L, Esposti Degli D and Belpoggi F: First experimental evidence of peritoneal and pleural mesotheliomas induced by fluoro-edenite fibres present in etnean volcanic material from Biancavilla (Sicily, Italy). Eur J Oncol. 9:169–175. 2004.

26 

Grosse Y, Loomis D, Guyton KZ, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Scoccianti C, Mattock H, et al: International Agency for Research on Cancer Monograph Working Group: Carcinogenicity of fluoro-edenite, silicon carbide fibres and whiskers, and carbon nanotubes. Lancet Oncol. 15:1427–1428. 2014. View Article : Google Scholar : PubMed/NCBI

27 

Bernstein D, Dunnigan J, Hesterberg T, Brown R, Velasco JAL, Barrera R, Hoskins J and Gibbs A: Health risk of chrysotile revisited. Crit Rev Toxicol. 43:154–183. 2013. View Article : Google Scholar : PubMed/NCBI

28 

Robinson BWS and Lake RA: Advances in malignant mesothelioma. N Engl J Med. 353:1591–1603. 2005. View Article : Google Scholar : PubMed/NCBI

29 

World Health Organization (WHO): Asbestos: elimination of asbestos-related diseases. http://www.who.int/mediacentre/factsheets/fs343/en/Accessed. January 21–2017.

30 

Ledda C and Rapisarda V: Malignant pleural mesothelioma: The need to move from research to clinical practice. Arch Med Res. 47:4072016. View Article : Google Scholar : PubMed/NCBI

31 

Ledda C, Loreto C, Matera S, Massimino N, Cannizzaro E, Musumeci A, Migliore M, Fenga C, Pomara C and Rapisarda V: Early effects of fluoro-edenite: Correlation between IL-18 serum levels and pleural and parenchymal abnormalities. Future Oncol. 12:59–62. 2016. View Article : Google Scholar : PubMed/NCBI

32 

Ledda C, Loreto C, Bracci M, Mangano D, Migliore M, Ricceri V, Musumeci A, Costa C, Pomara C and Rapisarda V: High risk of pleural plaques and parenchymal abnormalities in women living in Biancavilla (Italy). Future Oncol. 12:63–65. 2016. View Article : Google Scholar : PubMed/NCBI

33 

Ledda C, Pomara C, Bracci M, Mangano D, Ricceri V, Musumeci A, Ferrante M, Musumeci G, Loreto C, Fenga C, et al: Natural carcinogenic fiber and pleural plaques assessment in a general population: A cross-sectional study. Environ Res. 150:23–29. 2016. View Article : Google Scholar : PubMed/NCBI

34 

Ledda C, Loreto C, Pomara C, Rapisarda G, Fiore M, Ferrante M, Bracci M, Santarelli L, Fenga C and Rapisarda V: Sheep lymph-nodes as a biological indicator of environmental exposure to fluoro-edenite. Environ Res. 147:97–101. 2016. View Article : Google Scholar : PubMed/NCBI

35 

Rapisarda V, Ledda C, Migliore M, Salemi R, Musumeci A, Bracci M, Marconi A, Loreto C and Libra M: FBLN-3 as a biomarker of pleural plaques in workers occupationally exposed to carcinogenic fibers: A pilot study. Future Oncol. 11:(Suppl). 35–37. 2015. View Article : Google Scholar : PubMed/NCBI

36 

Fazzo L, Minelli G, De Santis M, Bruno C, Zona A, Marinaccio A, Conti S, Pirastu R and Comba P: Mesothelioma mortality surveillance and asbestos exposure tracking in Italy. Ann Ist Super Sanita. 48:300–310. 2012. View Article : Google Scholar : PubMed/NCBI

37 

Loreto C, Carnazza ML, Cardile V, Libra M, Lombardo L, Malaponte G, Martinez G, Musumeci G, Papa V and Cocco L: Mineral fiber-mediated activation of phosphoinositide-specific phospholipase c in human bronchoalveolar carcinoma-derived alveolar epithelial A549 cells. Int J Oncol. 34:371–376. 2009.PubMed/NCBI

38 

Musumeci G, Loreto C, Cardile V, Carnazza ML and Martinez G: Immunohistochemical expression of retinoblastoma and phospho-retinoblastoma protein in sheep lung exposed to fluoro-edenite fibers. Anat Sci Int. 85:74–78. 2010. View Article : Google Scholar : PubMed/NCBI

39 

Biggeri A, Pasetto R, Belli S, Bruno C, Di Maria G, Mastrantonio M, Trinca S, Uccelli R and Comba P: Mortality from chronic obstructive pulmonary disease and pleural mesothelioma in an area contaminated by natural fiber (fluoro-edenite). Scand J Work Environ Health. 30:249–252. 2004. View Article : Google Scholar : PubMed/NCBI

40 

Sayan M and Mossman BT: The NLRP3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseases. Part Fibre Toxicol. 13:512016. View Article : Google Scholar : PubMed/NCBI

41 

Churg A, Sun J and Zay K: Cigarette smoke increases amosite asbestos fiber binding to the surface of tracheal epithelial cells. Am J Physiol. 275:L502–508. 1998.PubMed/NCBI

42 

Kamp DW and Weitzman SA: The molecular basis of asbestos induced lung injury. Thorax. 54:638–652. 1999. View Article : Google Scholar : PubMed/NCBI

43 

Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, Sundaresan M, Finkel T and Goldschmidt-Clermont PJ: Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science. 275:1649–1652. 1997. View Article : Google Scholar : PubMed/NCBI

44 

Manna SK, Zhang HJ, Yan T, Oberley LW and Aggarwal BB: Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1. J Biol Chem. 273:13245–13254. 1998. View Article : Google Scholar : PubMed/NCBI

45 

Byrnes RW: Evidence for involvement of multiple iron species in DNA single-strand scission by H2O2 in HL-60 cells. Free Radic Biol Med. 20:399–406. 1996. View Article : Google Scholar : PubMed/NCBI

46 

Simeonova PP and Luster MI: Iron and reactive oxygen species in the asbestos-induced tumor necrosis factor-alpha response from alveolar macrophages. Am J Respir Cell Mol Biol. 12:676–683. 1995. View Article : Google Scholar : PubMed/NCBI

47 

Simeonova PP, Toriumi W, Kommineni C, Erkan M, Munson AE, Rom WN and Luster MI: Molecular regulation of IL-6 activation by asbestos in lung epithelial cells: Role of reactive oxygen species. J Immunol. 159:3921–3928. 1997.PubMed/NCBI

48 

Travaglione S, Bruni BM, Falzano L, Filippini P, Fabbri A, Paoletti L and Fiorentini C: Multinucleation and pro-inflammatory cytokine release promoted by fibrous fluoro-edenite in lung epithelial A549 cells. Toxicol In Vitro. 20:841–850. 2006. View Article : Google Scholar : PubMed/NCBI

49 

Travaglione S, Bruni B, Falzano L, Paoletti L and Fiorentini C: Effects of the new-identified amphibole fluoro-edenite in lung epithelial cells. Toxicol In Vitro. 17:547–552. 2003. View Article : Google Scholar : PubMed/NCBI

50 

Adachi Y, Aoki C, Yoshio-Hoshino N, Takayama K, Curiel DT and Nishimoto N: Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomas. Int J Cancer. 119:1303–1311. 2006. View Article : Google Scholar : PubMed/NCBI

51 

Galffy G, Mohammed KA, Nasreen N, Ward MJ and Antony VB: Inhibition of interleukin-8 reduces human malignant pleural mesothelioma propagation in nude mouse model. Oncol Res. 11:187–194. 1999.PubMed/NCBI

52 

Galffy G, Mohammed KA, Dowling PA, Nasreen N, Ward MJ and Antony VB: Interleukin 8: An autocrine growth factor for malignant mesothelioma. Cancer Res. 59:367–371. 1999.PubMed/NCBI

53 

Luo JL, Maeda S, Hsu LC, Yagita H and Karin M: Inhibition of NF-kappaB in cancer cells converts inflammation-induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression. Cancer Cell. 6:297–305. 2004. View Article : Google Scholar : PubMed/NCBI

54 

Clin B, Paris C, Ameille J, Brochard P, Conso F, Gislard A, Laurent F, Letourneux M, Luc A, Schorle E, et al: Do asbestos-related pleural plaques on HRCT scans cause restrictive impairment in the absence of pulmonary fibrosis? Thorax. 66:985–991. 2011. View Article : Google Scholar : PubMed/NCBI

55 

Laurent F, Paris C, Ferretti GR, Beigelman C, Montaudon M, Latrabe V, Jankowski A, Badachi Y, Clin B, Gislard A, et al: Inter-reader agreement in HRCT detection of pleural plaques and asbestosis in participants with previous occupational exposure to asbestos. Occup Environ Med. 71:865–870. 2014. View Article : Google Scholar : PubMed/NCBI

56 

Rapisarda V, Ledda C, Ricceri V, Arena F, Musumeci A, Marconi A, Fago L, Bracci M, Santarelli L and Ferrante M: Detection of pleural plaques in workers exposed to inhalation of natural fluoro-edenite fibres. Oncol Lett. 9:2046–2052. 2015.PubMed/NCBI

57 

Maxim LD, Niebo R and Utell MJ: Are pleural plaques an appropriate endpoint for risk analyses? Inhal Toxicol. 27:321–334. 2015. View Article : Google Scholar : PubMed/NCBI

58 

Wang Y, Faux SP, Hallden G, Kirn DH, Houghton CE, Lemoine NR and Patrick G: Interleukin-1β and tumour necrosis factor-α promote the transformation of human immortalised mesothelial cells by erionite. Int J Oncol. 25:173–178. 2004.PubMed/NCBI

59 

Zanella CL, Posada J, Tritton TR and Mossman BT: Asbestos causes stimulation of the extracellular signal-regulated kinase 1 mitogen-activated protein kinase cascade after phosphorylation of the epidermal growth factor receptor. Cancer Res. 56:5334–5338. 1996.PubMed/NCBI

60 

Mantovani A, Allavena P, Sozzani S, Vecchi A, Locati M and Sica A: Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors. Semin Cancer Biol. 14:155–160. 2004. View Article : Google Scholar : PubMed/NCBI

61 

Eisenbarth SC and Flavell RA: Innate instruction of adaptive immunity revisited: The inflammasome. EMBO Mol Med. 1:92–98. 2009. View Article : Google Scholar : PubMed/NCBI

62 

Dostert C, Pétrilli V, Van Bruggen R, Steele C, Mossman BT and Tschopp J: Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science. 320:674–677. 2008. View Article : Google Scholar : PubMed/NCBI

63 

Hillegass JM, Miller JM, MacPherson MB, Westbom CM, Sayan M, Thompson JK, Macura SL, Perkins TN, Beuschel SL, Alexeeva V, et al: Asbestos and erionite prime and activate the NLRP3 inflammasome that stimulates autocrine cytokine release in human mesothelial cells. Part Fibre Toxicol. 10:392013. View Article : Google Scholar : PubMed/NCBI

64 

Fox SA, Loh SS, Mahendran SK and Garlepp MJ: Regulated chemokine gene expression in mouse mesothelioma and mesothelial cells: TNF-α upregulates both CC and CXC chemokine genes. Oncol Rep. 28:707–713. 2012.PubMed/NCBI

65 

Martinon F, Burns K and Tschopp J: The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol Cell. 10:417–426. 2002. View Article : Google Scholar : PubMed/NCBI

66 

Dinarello CA: Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 27:519–550. 2009. View Article : Google Scholar : PubMed/NCBI

67 

Fink SL and Cookson BT: Apoptosis, pyroptosis, and necrosis: Mechanistic description of dead and dying eukaryotic cells. Infect Immun. 73:1907–1916. 2005. View Article : Google Scholar : PubMed/NCBI

68 

Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN and Tschopp J: NALP3 forms an IL-1β-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity. 20:319–325. 2004. View Article : Google Scholar : PubMed/NCBI

69 

Dinarello CA: Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood. 117:3720–3732. 2011. View Article : Google Scholar : PubMed/NCBI

70 

Sims JE and Smith DE: The IL-1 family: Regulators of immunity. Nat Rev Immunol. 10:89–102. 2010. View Article : Google Scholar : PubMed/NCBI

71 

Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, Giri JG, Dower SK, Sims JE and Mantovani A: Interleukin-1 type II receptor: A decoy target for IL-1 that is regulated by IL-4. Science. 261:472–475. 1993. View Article : Google Scholar : PubMed/NCBI

72 

Kim SH, Eisenstein M, Reznikov L, Fantuzzi G, Novick D, Rubinstein M and Dinarello CA: Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. Proc Natl Acad Sci USA. 97:1190–1195. 2000. View Article : Google Scholar : PubMed/NCBI

73 

Tschopp J, Martinon F and Burns K: NALPs: A novel protein family involved in inflammation. Nat Rev Mol Cell Biol. 4:95–104. 2003. View Article : Google Scholar : PubMed/NCBI

74 

Bank U and Ansorge S: More than destructive: Neutrophil-derived serine proteases in cytokine bioactivity control. J Leukoc Biol. 69:197–206. 2001.PubMed/NCBI

75 

Martinon F, Agostini L, Meylan E and Tschopp J: Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome. Curr Biol. 14:1929–1934. 2004. View Article : Google Scholar : PubMed/NCBI

76 

Kanneganti TD, Ozören N, Body-Malapel M, Amer A, Park JH, Franchi L, Whitfield J, Barchet W, Colonna M, Vandenabeele P, et al: Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature. 440:233–236. 2006. View Article : Google Scholar : PubMed/NCBI

77 

Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M, Lee WP, Weinrauch Y, Monack DM and Dixit VM: Cryopyrin activates the inflammasome in response to toxins and ATP. Nature. 440:228–232. 2006. View Article : Google Scholar : PubMed/NCBI

78 

Eisenbarth SC, Colegio OR, O'Connor W Jr, Sutterwala FS and Flavell RA: Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature. 453:1122–1126. 2008. View Article : Google Scholar : PubMed/NCBI

79 

Krakowski M and Owens T: Interferon-γ confers resistance to experimental allergic encephalomyelitis. Eur J Immunol. 26:1641–1646. 1996. View Article : Google Scholar : PubMed/NCBI

80 

Vermeire K, Heremans H, Vandeputte M, Huang S, Billiau A and Matthys P: Accelerated collagen-induced arthritis in IFN-γ receptor-deficient mice. J Immunol. 158:5507–5513. 1997.PubMed/NCBI

81 

Chang JT, Segal BM, Nakanishi K, Okamura H and Shevach EM: The costimulatory effect of IL-18 on the induction of antigen-specific IFN-γ production by resting T cells is IL-12 dependent and is mediated by up-regulation of the IL-12 receptor β2 subunit. Eur J Immunol. 30:1113–1119. 2000. View Article : Google Scholar : PubMed/NCBI

82 

Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B, Lucian L, To W, Kwan S, Churakova T, et al: Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature. 421:744–748. 2003. View Article : Google Scholar : PubMed/NCBI

83 

Mills KHG, Dungan LS, Jones SA and Harris J: The role of inflammasome-derived IL-1 in driving IL-17 responses. J Leukoc Biol. 93:489–497. 2013. View Article : Google Scholar : PubMed/NCBI

84 

Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL and Kuchroo VK: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 441:235–238. 2006. View Article : Google Scholar : PubMed/NCBI

85 

Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO, Hatton RD, Wahl SM, Schoeb TR and Weaver CT: Transforming growth factor-β induces development of the T(H)17 lineage. Nature. 441:231–234. 2006. View Article : Google Scholar : PubMed/NCBI

86 

Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM and Stockinger B: TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 24:179–189. 2006. View Article : Google Scholar : PubMed/NCBI

87 

Zielinski CE, Mele F, Aschenbrenner D, Jarrossay D, Ronchi F, Gattorno M, Monticelli S, Lanzavecchia A and Sallusto F: Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β. Nature. 484:514–518. 2012. View Article : Google Scholar : PubMed/NCBI

88 

Comar M, Zanotta N, Bonotti A, Tognon M, Negro C, Cristaudo A and Bovenzi M: Increased levels of C-C chemokine RANTES in asbestos exposed workers and in malignant mesothelioma patients from an hyperendemic area. PLoS One. 9:e1048482014. View Article : Google Scholar : PubMed/NCBI

89 

Davis GS, Pfeiffer LM and Hemenway DR: Persistent overexpression of interleukin-1β and tumor necrosis factor-α in murine silicosis. J Environ Pathol Toxicol Oncol. 17:99–114. 1998.PubMed/NCBI

90 

Pan LH, Ohtani H, Yamauchi K and Nagura H: Co-expression of TNFα and IL-1β in human acute pulmonary fibrotic diseases: An immunohistochemical analysis. Pathol Int. 46:91–99. 1996. View Article : Google Scholar : PubMed/NCBI

91 

Beamer CA and Holian A: Scavenger receptor class A type I/II (CD204) null mice fail to develop fibrosis following silica exposure. Am J Physiol Lung Cell Mol Physiol. 289:L186–L195. 2005. View Article : Google Scholar : PubMed/NCBI

92 

Holley JA, Janssen YMW, Mossman BT and Taatjes DJ: Increased manganese superoxide dismutase protein in type II epithelial cells of rat lungs after inhalation of crocidolite asbestos or cristobalite silica. Am J Pathol. 141:475–485. 1992.PubMed/NCBI

93 

Porter DW, Hubbs AF, Chen BT, McKinney W, Mercer RR, Wolfarth MG, Battelli L, Wu N, Sriram K, Leonard S, et al: Acute pulmonary dose-responses to inhaled multi-walled carbon nanotubes. Nanotoxicology. 7:1179–1194. 2013. View Article : Google Scholar : PubMed/NCBI

94 

Liu RM: Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis. Antioxid Redox Signal. 10:303–319. 2008. View Article : Google Scholar : PubMed/NCBI

95 

Carbone M and Yang H: Molecular pathways: Targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma. Clin Cancer Res. 18:598–604. 2012. View Article : Google Scholar : PubMed/NCBI

96 

Donaldson K, Poland CA, Murphy FA, MacFarlane M, Chernova T and Schinwald A: Pulmonary toxicity of carbon nanotubes and asbestos - similarities and differences. Adv Drug Deliv Rev. 65:2078–2086. 2013. View Article : Google Scholar : PubMed/NCBI

97 

Goldberg JL, Zanella CL, Janssen YMW, Timblin CR, Jimenez LA, Vacek P, Taatjes DJ and Mossman BT: Novel cell imaging techniques show induction of apoptosis and proliferation in mesothelial cells by asbestos. Am J Respir Cell Mol Biol. 17:265–271. 1997. View Article : Google Scholar : PubMed/NCBI

98 

Sekido Y: Molecular pathogenesis of malignant mesothelioma. Carcinogenesis. 34:1413–1419. 2013. View Article : Google Scholar : PubMed/NCBI

99 

Kitasato Y, Hoshino T, Okamoto M, Kato S, Koda Y, Nagata N, Kinoshita M, Koga H, Yoon DY, Asao H, et al: Enhanced expression of interleukin-18 and its receptor in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol. 31:619–625. 2004. View Article : Google Scholar : PubMed/NCBI

100 

Lindroos PM, Coin PG, Osornio-Vargas AR and Bonner JC: Interleukin 1 beta (IL-1 beta) and the IL-1 beta-alpha 2-macroglobulin complex upregulate the platelet-derived growth factor alpha-receptor on rat pulmonary fibroblasts. Am J Respir Cell Mol Biol. 13:455–465. 1995. View Article : Google Scholar : PubMed/NCBI

101 

Sabo-Attwood T, Ramos-Nino M, Bond J, Butnor KJ, Heintz N, Gruber AD, Steele C, Taatjes DJ, Vacek P and Mossman BT: Gene expression profiles reveal increased mClca3 (Gob5) expression and mucin production in a murine model of asbestos-induced fibrogenesis. Am J Pathol. 167:1243–1256. 2005. View Article : Google Scholar : PubMed/NCBI

102 

Musumeci G, Loreto C, Giunta S, Rapisarda V, Szychlinska MA, Imbesi R, Castorina A, Annese T, Castorina S, Castrogiovanni P, et al: Angiogenesis correlates with macrophage and mast cell infiltration in lung tissue of animals exposed to fluoro-edenite fibers. Exp Cell Res. 346:91–98. 2016. View Article : Google Scholar : PubMed/NCBI

103 

Cardile V, Lombardo L, Belluso E, Panico A, Renis M, Gianfagna A and Balazy M: Fluoro-edenite fibers induce expression of Hsp70 and inflammatory response. Int J Environ Res Public Health. 4:195–202. 2007. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Ledda C, Costa C, Matera S, Puglisi B, Costanzo V, Bracci M, Fenga C, Rapisarda V and Loreto C: Immunomodulatory effects in workers exposed to naturally occurring asbestos fibers. Mol Med Rep 15: 3372-3378, 2017.
APA
Ledda, C., Costa, C., Matera, S., Puglisi, B., Costanzo, V., Bracci, M. ... Loreto, C. (2017). Immunomodulatory effects in workers exposed to naturally occurring asbestos fibers. Molecular Medicine Reports, 15, 3372-3378. https://doi.org/10.3892/mmr.2017.6384
MLA
Ledda, C., Costa, C., Matera, S., Puglisi, B., Costanzo, V., Bracci, M., Fenga, C., Rapisarda, V., Loreto, C."Immunomodulatory effects in workers exposed to naturally occurring asbestos fibers". Molecular Medicine Reports 15.5 (2017): 3372-3378.
Chicago
Ledda, C., Costa, C., Matera, S., Puglisi, B., Costanzo, V., Bracci, M., Fenga, C., Rapisarda, V., Loreto, C."Immunomodulatory effects in workers exposed to naturally occurring asbestos fibers". Molecular Medicine Reports 15, no. 5 (2017): 3372-3378. https://doi.org/10.3892/mmr.2017.6384
Copy and paste a formatted citation
x
Spandidos Publications style
Ledda C, Costa C, Matera S, Puglisi B, Costanzo V, Bracci M, Fenga C, Rapisarda V and Loreto C: Immunomodulatory effects in workers exposed to naturally occurring asbestos fibers. Mol Med Rep 15: 3372-3378, 2017.
APA
Ledda, C., Costa, C., Matera, S., Puglisi, B., Costanzo, V., Bracci, M. ... Loreto, C. (2017). Immunomodulatory effects in workers exposed to naturally occurring asbestos fibers. Molecular Medicine Reports, 15, 3372-3378. https://doi.org/10.3892/mmr.2017.6384
MLA
Ledda, C., Costa, C., Matera, S., Puglisi, B., Costanzo, V., Bracci, M., Fenga, C., Rapisarda, V., Loreto, C."Immunomodulatory effects in workers exposed to naturally occurring asbestos fibers". Molecular Medicine Reports 15.5 (2017): 3372-3378.
Chicago
Ledda, C., Costa, C., Matera, S., Puglisi, B., Costanzo, V., Bracci, M., Fenga, C., Rapisarda, V., Loreto, C."Immunomodulatory effects in workers exposed to naturally occurring asbestos fibers". Molecular Medicine Reports 15, no. 5 (2017): 3372-3378. https://doi.org/10.3892/mmr.2017.6384
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team